SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Johnston Joseph Patrick

(Last)(First)(Middle)
C/O XYLEM INC.
301 WATER STREET SE

(Street)
WASHINGTON DISTRICT OF COLUMBIA 20003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026
3. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & President, AW
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock1,640(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy) (2)03/02/2036Common Stock1,688$128.98D
Stock Options (Right to Buy) (3)03/05/2035Common Stock1,353$129.67D
Stock Options (Right to Buy) (4)03/01/2034Common Stock1,322$127.94D
Stock Options (Right to Buy) (5)03/01/2033Common Stock1,004$101.09D
Stock Options (Right to Buy) (6)03/01/2032Common Stock524$86.76D
Explanation of Responses:
1. Reflects restricted stock units which are scheduled to vest as follows: 289 on March 1, 2027, 129 on March 5, 2027, 398 on June 1, 2027, 537 on March 1, 2028, 129 on March 5, 2028, 158 on March 1, 2029. Each restricted stock unit represents the right to receive one share of common stock upon vesting.
2. These options are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
3. 451 options are fully vested and exercisable, 451 are scheduled to vest on March 5, 2027, and 451 are scheduled to vest on March 5, 2028.
4. 881 options are fully vested and exercisable, 441 are scheduled to vest on March 1, 2027.
5. 1,004 options are fully vested and exercisable.
6. 524 options are fully vested and exercisable.
Mike Nazario, by power of attorney for Joseph Patrick Johnston07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)